semaglutide dr reddy's Indian drugmaker gearing up for March debut of generic Obeda, sources say India's Dr Reddy's plans to

Nicolau, J., Pujol, A., Tofe, S., Bonet, A

[1] In STEP UP trial data, average weight loss at 72 weeks was greater with semaglutide 7.2mg than with 2.4mg, but trial averages do not predict an individual result

Specifically formulated for GLP-1 users

Genetic factors revealed by the Precision Peptide Genetic Test can also explain why some patients experience stronger side effects and benefit from modified dosing approaches

Although GLP-1(9-36) was previously considered biologically inactive, emerging evidence indicate that it exerts cardioprotective and insulinotropic actions

According to IQVIA ProVoice survey for 12 months ending March 31, 2026